Skip to main content

The Use of Quinolones for the Treatment of Shigellosis in Travelers

  • Conference paper
Use of Quinolones in Travel Medicine
  • 35 Accesses

Abstract

Shigellosis remains a major public health problem wherever sanitary conditions are poor. In developed countries, Shigella infections are most common in institutions for the mentally retarded, in day care centers, and among the poor. Examples of the latter are persons living in the inner cities or the Indian reservations of the United States where the incidence of shigellosis is much higher than for the general population [11].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bennish ML, Eusof A, Kay B, Wierzba T (1985) Multiresistant Shigella infections in Bangladesh. Lancet 2: 441

    Article  PubMed  CAS  Google Scholar 

  2. Benish ML, Harris JR, Wojtyniak BJ, Struelens M (1990) Death in shigellosis: incidence and risk factors in hospitalized patients. J Infect Dis 161: 500–506

    Article  Google Scholar 

  3. Bennish ML, Salam MA, Haider R, Barza M (1990) Therapy for shigellosis: II. Randomized double-blind comparison of ciprofloxacin and ampicillin. J Infect Dis 162: 7112–7116

    Google Scholar 

  4. Bennish ML, Azard AK,Yousefzadeh D (1991) Intestinal obstruction during shigellosis: incidence, clinical features, risk factors, and outcome. Gastroen-terology 101: 626–634

    CAS  Google Scholar 

  5. Centers for Disease Control (1986) Multiply resistant shigellosis in a daycare center, Texas. MMWR 35: 753–755

    Google Scholar 

  6. Centers for Disease Control (1987) Nationwide dissemination of multiply resistant Shigella sonnei following a common-source outbreak. MMWR 36: 633–634

    Google Scholar 

  7. Centers for Disease Control (1991) Shigella dysenteriae type 1 - Guatemala, 1991. MMWR 40: 421–428

    Google Scholar 

  8. DeMol P, Mets T, Lagasse R,Vandepitte J, Mutwewingabo A, Butzler J-P (1987) Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid. J Antimicrob Chemother 19: 695–698

    Article  CAS  Google Scholar 

  9. DuPont HL, Levine MM, Hornick RB, Formal SB (1989) Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis 159: 1126–1128

    Article  PubMed  CAS  Google Scholar 

  10. Gotuzzo E, Oberhelman RA, Maguiña C, Berry SJ,Yi A, Guzman M, Ruiz R, Leon-Barua R, Sack RB (1989) Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults. Antimicrob Agents Chemother 33: 1101–1104

    CAS  Google Scholar 

  11. Keusch GT, Bennish ML (1991) Shigellosis. In: Evans AS, Brachman PS (eds) Bacterial infections of humans. Epidemiology and control. Plenum Press, New York, pp 593–620

    Google Scholar 

  12. Khan WA, Salam MA, Khan AM, Bennish ML (1991) Randomized, double-blinded comparison of short course ciprofloxacin with standard five day therapy in the treatment of severe shigellosis. In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago. American Society for Microbiology

    Google Scholar 

  13. Koster F, Levin J, Walker L,Tunk KSK, Gilman RH, Rahaman MM, Majid MA, Islam S, Williams RC (1978) Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med 298: 927–933

    Google Scholar 

  14. Parsonnet J, Greene KD, Gerber AR, Tauxe RV, Aguilar OCJ, Blake PA (1989) Shigella dysenteriae type 1 infections in US travellers to Mexico, 1988. Lancet 2: 543–546

    Google Scholar 

  15. Rogerie F, Ott D,Vandepitte J,Verbist L, Lemmens P, Habiyaremye I (1986) Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults. Antimicrob Agents Chemother 29: 883–886

    PubMed  CAS  Google Scholar 

  16. Ronsmans C, Bennish ML,WierzbaT (1988) Diagnosis and management of dysentery by community health workers. Lancet 2: 552–555

    CAS  Google Scholar 

  17. Salam MA, Bennish ML (1988) Therapy for shigellosis: 1. Randomized, double-blind trial of nalidixic acid in childhood shigellosis. J Pediatr 113: 901–907

    Google Scholar 

  18. Salam MA, Bennish ML (1991) Antimicrobial therapy for shigellosis. Rev Infect Dis 13 (Suppl 4): S332–341

    Article  PubMed  Google Scholar 

  19. Varsano I, Eidlitz-Marcus T, Nussinovitch M, Elian I (1991) Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children. J Pediatr 118: 627–632

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Bennish, M.L. (1992). The Use of Quinolones for the Treatment of Shigellosis in Travelers. In: DuPont, H.L. (eds) Use of Quinolones in Travel Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77077-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77077-7_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54778-5

  • Online ISBN: 978-3-642-77077-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics